In the past, biologically-active peptides — small proteins like neurotoxins and hormones that act on cell receptors to alter physiology — were purified from native sources like venoms and then panels of variants were produced in bacteria, or synthesized, to study the structural basis for receptor interaction. A new technique called zombie scanning renders these older processes obsolete.